Oral doxifluridine plus levoleucovorin i
โ
Emilio Bajetta; Laura Biganzoli; Carlo Carnaghi; Maria Di Bartolomeo; Ivo Spagno
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 81 KB
๐ 2 views
## BACKGROUND. There currently is no agreement regarding the appropriate treatment of elderly patients with advanced breast carcinoma (ABC). Doxifluridine (5-dFUR), a prodrug of 5-fluorouracil, has been found to be effective in this entity, but its use is limited by neurotoxicity and cardiotoxici